GlassScriptPhysician profile
Jackie Williams
NPI 1194234146
$5,375.29
in general payments reported to CMS, 2019-2025
32 companies · $859 in 2025
The $859 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $522 · 2022: $1,223 · 2023: $1,127 · 2024: $1,645 · 2025: $859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,768 · Travel and Lodging: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,767.76 |
| Travel and Lodging | $863.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,176.88 | 2023-2025 | Varithena Administration Pack |
| Medtronic, INC. | $1,032.62 | 2022-2025 | Venaseal, In.Pact Admiral |
| E.R. Squibb & Sons, L.L.C. | $369.20 | 2021-2025 | Zeposia |
| Janssen Pharmaceuticals, INC | $347.39 | 2021-2023 | Xarelto |
| Abbvie INC. | $258.39 | 2023 | |
| Alexion Pharmaceuticals, INC. | $199.25 | 2024 | Ultomiris |
| Bard Peripheral Vascular, INC. | $189.75 | 2022-2025 | Rotarexs 6 F X 135 Cm |
| Endologix LLC | $171.61 | 2021-2025 | Endocross Device, Torus Stent Graft System |
| Biotissue Holdings INC. | $164.78 | 2024 | |
| Silk Road Medical, INC. | $143.44 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Genzyme Corporation | $136.29 | 2023 | |
| Novo Nordisk INC | $130.06 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $124.67 | 2024 | Rexulti |
| Corium, LLC | $123.00 | 2023 | Azstarys |
| Idorsia Pharmaceuticals US INC | $112.86 | 2023 | Quviviq |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $74.15 | 2021 | |
| Lemaitre Vascular, INC. | $63.67 | 2022-2025 | Artegraft Vascular Graft |
| Edwards Lifesciences Corporation | $63.26 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $62.74 | 2023 | Crysvita |
| Neurelis, INC. | $58.48 | 2024 | Valtoco |
| Sage Therapeutics, LLC | $54.59 | 2023 | |
| Kci USA, INC. | $48.65 | 2023 | Prevena, V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Angiodynamics, INC. | $46.71 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Lilly USA, LLC | $43.43 | 2022 | |
| Solventum Corporation | $33.03 | 2024 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, V.A.C. Veraflo |
| Neuros Medical, INC. | $27.25 | 2025 | Altius |
| Smith+Nephew, INC. | $23.50 | 2023 | Collagenase Santyl |
| Tactile Systems Technology INC | $23.03 | 2025 | Nimbl, Flexitouch Plus |
| Vertex Pharmaceuticals Incorporated | $21.26 | 2025 | |
| Integra Lifesciences Corporation | $19.86 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Convatec INC. | $17.79 | 2022 | |
| W. L. Gore & Associates, INC. | $13.70 | 2025 | Gore Excluder Aaa Endoprosthesis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackie Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.